{"entity":{"type":"insider","cik":"0001685138","url":"/insider/0001685138","json_url":"/insider/0001685138.json","name":"Malin Life Sciences Holdings Ltd","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":8,"first":"2016-09-28","last":"2022-08-10","span_basis":"filed_date"},"name_variants":[{"name":"Malin Life Sciences Holdings Ltd","source":"filing","n_filings":8,"first_seen":"2016-09-28","last_seen":"2022-08-10"}],"transactions":[{"id":6403467,"accession":"0001104659-22-088886","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-088886","line_url":"/filing/0001104659-22-088886#line-1","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001685138","owner_name":"Malin Life Sciences Holdings Ltd","owner_display_name":"Malin Life Sciences Holdings Ltd","owner_url":"/insider/0001685138","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2150000.0,"shares_display":"2,150,000","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":7525000.0,"total_display":"7,525,000.00","total_whole":"7,525,000","shares_owned_after":11835673.0,"shares_owned_after_display":"11,835,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-10","scope":"insider"},{"id":5207120,"accession":"0001104659-21-146952","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-146952","line_url":"/filing/0001104659-21-146952#line-1","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001685138","owner_name":"Malin Life Sciences Holdings Ltd","owner_display_name":"Malin Life Sciences Holdings Ltd","owner_url":"/insider/0001685138","role":"Ten percent owner, Other","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1828.0,"shares_display":"1,828","price_per_share":6.9,"price_display":"6.90","price_state":"stated","total_value":12613.2,"total_display":"12,613.20","total_whole":"12,613","shares_owned_after":9685673.0,"shares_owned_after_display":"9,685,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-06","filed_date":"2021-12-07","scope":"insider"},{"id":4721078,"accession":"0001104659-21-146000","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-146000","line_url":"/filing/0001104659-21-146000#line-3","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001685138","owner_name":"Malin Life Sciences Holdings Ltd","owner_display_name":"Malin Life Sciences Holdings Ltd","owner_url":"/insider/0001685138","role":"Ten percent owner, Other","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4296.0,"shares_display":"4,296","price_per_share":6.8786,"price_display":"6.88","price_state":"stated","total_value":29550.4656,"total_display":"29,550.47","total_whole":"29,550","shares_owned_after":9683845.0,"shares_owned_after_display":"9,683,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-02","filed_date":"2021-12-02","scope":"insider"},{"id":4721074,"accession":"0001104659-21-146000","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-146000","line_url":"/filing/0001104659-21-146000#line-2","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001685138","owner_name":"Malin Life Sciences Holdings Ltd","owner_display_name":"Malin Life Sciences Holdings Ltd","owner_url":"/insider/0001685138","role":"Ten percent owner, Other","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18365.0,"shares_display":"18,365","price_per_share":6.8503,"price_display":"6.85","price_state":"stated","total_value":125805.7595,"total_display":"125,805.76","total_whole":"125,806","shares_owned_after":9679549.0,"shares_owned_after_display":"9,679,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-02","scope":"insider"},{"id":4721068,"accession":"0001104659-21-146000","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-146000","line_url":"/filing/0001104659-21-146000#line-1","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001685138","owner_name":"Malin Life Sciences Holdings Ltd","owner_display_name":"Malin Life Sciences Holdings Ltd","owner_url":"/insider/0001685138","role":"Ten percent owner, Other","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28592.0,"shares_display":"28,592","price_per_share":6.8494,"price_display":"6.85","price_state":"stated","total_value":195838.0448,"total_display":"195,838.04","total_whole":"195,838","shares_owned_after":9661184.0,"shares_owned_after_display":"9,661,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-30","filed_date":"2021-12-02","scope":"insider"},{"id":4617614,"accession":"0001104659-21-144590","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-144590","line_url":"/filing/0001104659-21-144590#line-3","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001685138","owner_name":"Malin Life Sciences Holdings Ltd","owner_display_name":"Malin Life Sciences Holdings Ltd","owner_url":"/insider/0001685138","role":"Ten percent owner, Other","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11057.0,"shares_display":"11,057","price_per_share":6.8924,"price_display":"6.89","price_state":"stated","total_value":76209.2668,"total_display":"76,209.27","total_whole":"76,209","shares_owned_after":9632592.0,"shares_owned_after_display":"9,632,592","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-29","filed_date":"2021-11-29","scope":"insider"},{"id":4617607,"accession":"0001104659-21-144590","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-144590","line_url":"/filing/0001104659-21-144590#line-2","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001685138","owner_name":"Malin Life Sciences Holdings Ltd","owner_display_name":"Malin Life Sciences Holdings Ltd","owner_url":"/insider/0001685138","role":"Ten percent owner, Other","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27251.0,"shares_display":"27,251","price_per_share":6.8068,"price_display":"6.81","price_state":"stated","total_value":185492.1068,"total_display":"185,492.11","total_whole":"185,492","shares_owned_after":9621535.0,"shares_owned_after_display":"9,621,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-26","filed_date":"2021-11-29","scope":"insider"},{"id":4617601,"accession":"0001104659-21-144590","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-144590","line_url":"/filing/0001104659-21-144590#line-1","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001685138","owner_name":"Malin Life Sciences Holdings Ltd","owner_display_name":"Malin Life Sciences Holdings Ltd","owner_url":"/insider/0001685138","role":"Ten percent owner, Other","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1054.0,"shares_display":"1,054","price_per_share":6.8882,"price_display":"6.89","price_state":"stated","total_value":7260.1628,"total_display":"7,260.16","total_whole":"7,260","shares_owned_after":9594284.0,"shares_owned_after_display":"9,594,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-24","filed_date":"2021-11-29","scope":"insider"},{"id":4101607,"accession":"0001104659-21-143142","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-143142","line_url":"/filing/0001104659-21-143142#line-2","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001685138","owner_name":"Malin Life Sciences Holdings Ltd","owner_display_name":"Malin Life Sciences Holdings Ltd","owner_url":"/insider/0001685138","role":"Ten percent owner, Other","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14625.0,"shares_display":"14,625","price_per_share":6.7685,"price_display":"6.77","price_state":"stated","total_value":98989.3125,"total_display":"98,989.31","total_whole":"98,989","shares_owned_after":9593230.0,"shares_owned_after_display":"9,593,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-23","filed_date":"2021-11-23","scope":"insider"},{"id":4101602,"accession":"0001104659-21-143142","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-143142","line_url":"/filing/0001104659-21-143142#line-1","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001685138","owner_name":"Malin Life Sciences Holdings Ltd","owner_display_name":"Malin Life Sciences Holdings Ltd","owner_url":"/insider/0001685138","role":"Ten percent owner, Other","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11104.0,"shares_display":"11,104","price_per_share":7.4433,"price_display":"7.44","price_state":"stated","total_value":82650.4032,"total_display":"82,650.40","total_whole":"82,650","shares_owned_after":9578605.0,"shares_owned_after_display":"9,578,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-19","filed_date":"2021-11-23","scope":"insider"},{"id":5460246,"accession":"0001104659-21-141457","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-141457","line_url":"/filing/0001104659-21-141457#line-3","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001685138","owner_name":"Malin Life Sciences Holdings Ltd","owner_display_name":"Malin Life Sciences Holdings Ltd","owner_url":"/insider/0001685138","role":"Ten percent owner, Other","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":71312.0,"shares_display":"71,312","price_per_share":7.1753,"price_display":"7.18","price_state":"stated","total_value":511684.9936,"total_display":"511,684.99","total_whole":"511,685","shares_owned_after":9567501.0,"shares_owned_after_display":"9,567,501","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-18","scope":"insider"},{"id":5460242,"accession":"0001104659-21-141457","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-141457","line_url":"/filing/0001104659-21-141457#line-2","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001685138","owner_name":"Malin Life Sciences Holdings Ltd","owner_display_name":"Malin Life Sciences Holdings Ltd","owner_url":"/insider/0001685138","role":"Ten percent owner, Other","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":280384.0,"shares_display":"280,384","price_per_share":7.2109,"price_display":"7.21","price_state":"stated","total_value":2021820.9856,"total_display":"2,021,820.99","total_whole":"2,021,821","shares_owned_after":9496189.0,"shares_owned_after_display":"9,496,189","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-17","filed_date":"2021-11-18","scope":"insider"},{"id":5460239,"accession":"0001104659-21-141457","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-141457","line_url":"/filing/0001104659-21-141457#line-1","is_derivative":false,"issuer_cik":"0001661460","issuer_name":"Poseida Therapeutics, Inc.","issuer_ticker":"PSTX","issuer_name_source":null,"issuer_url":"/issuer/0001661460","owner_cik":"0001685138","owner_name":"Malin Life Sciences Holdings Ltd","owner_display_name":"Malin Life Sciences Holdings Ltd","owner_url":"/insider/0001685138","role":"Ten percent owner, Other","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27680.0,"shares_display":"27,680","price_per_share":7.167,"price_display":"7.17","price_state":"stated","total_value":198382.56,"total_display":"198,382.56","total_whole":"198,383","shares_owned_after":9215805.0,"shares_owned_after_display":"9,215,805","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-18","scope":"insider"},{"id":7833799,"accession":"0001104659-19-039167","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-039167","line_url":"/filing/0001104659-19-039167#line-3","is_derivative":false,"issuer_cik":"0001467154","issuer_name":"Novan, Inc.","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0001467154","owner_cik":null,"owner_name":"Malin Corp plc; Malin Life Sciences Holdings Ltd","owner_display_name":"Malin Corp plc","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6287.0,"shares_display":"6,287","price_per_share":2.75,"price_display":"2.75","price_state":"stated","total_value":17289.25,"total_display":"17,289.25","total_whole":"17,289","shares_owned_after":2598485.0,"shares_owned_after_display":"2,598,485","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-02","filed_date":"2019-07-02","scope":"insider"},{"id":7833796,"accession":"0001104659-19-039167","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-039167","line_url":"/filing/0001104659-19-039167#line-2","is_derivative":false,"issuer_cik":"0001467154","issuer_name":"Novan, Inc.","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0001467154","owner_cik":null,"owner_name":"Malin Corp plc; Malin Life Sciences Holdings Ltd","owner_display_name":"Malin Corp plc","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":913.0,"shares_display":"913","price_per_share":2.74,"price_display":"2.74","price_state":"stated","total_value":2501.62,"total_display":"2,501.62","total_whole":"2,502","shares_owned_after":2604772.0,"shares_owned_after_display":"2,604,772","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-01","filed_date":"2019-07-02","scope":"insider"},{"id":7833793,"accession":"0001104659-19-039167","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-039167","line_url":"/filing/0001104659-19-039167#line-1","is_derivative":false,"issuer_cik":"0001467154","issuer_name":"Novan, Inc.","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0001467154","owner_cik":null,"owner_name":"Malin Corp plc; Malin Life Sciences Holdings Ltd","owner_display_name":"Malin Corp plc","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17800.0,"shares_display":"17,800","price_per_share":2.69,"price_display":"2.69","price_state":"stated","total_value":47882.0,"total_display":"47,882.00","total_whole":"47,882","shares_owned_after":2605685.0,"shares_owned_after_display":"2,605,685","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-28","filed_date":"2019-07-02","scope":"insider"},{"id":3274313,"accession":"0000899243-16-030259","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-030259","line_url":"/filing/0000899243-16-030259#line-2","is_derivative":false,"issuer_cik":"0001467154","issuer_name":"Novan, Inc.","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0001467154","owner_cik":null,"owner_name":"Malin Life Sciences Holdings Ltd; Malin Corp plc","owner_display_name":"Malin Life Sciences Holdings Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800000.0,"shares_display":"800,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":8800000.0,"total_display":"8,800,000.00","total_whole":"8,800,000","shares_owned_after":2623485.0,"shares_owned_after_display":"2,623,485","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-26","filed_date":"2016-09-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":13,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001661460","name":"Poseida Therapeutics, Inc.","url":"/issuer/0001661460","role":"Ten percent owner, Other","n_filings":6,"first_seen":"2021-11-18","last_seen":"2022-08-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001467154","name":"Novan, Inc.","url":"/issuer/0001467154","role":"Ten percent owner","n_filings":2,"first_seen":"2016-09-28","last_seen":"2019-07-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001685138","retrieved_at":"2026-08-24T16:24:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}